Review Article - International Journal of Clinical Rheumatology (2023) Volume 18, Issue 3

Does the aim justify the means when using a temporal artery biopsy to diagnose giant cell arteritis?

Bowling K*

Peninsula Deanery, Torbay Hospital, South Devon Healthcare Trust, Torquay, United Kingdom

*Corresponding Author:
Bowling K
Peninsula Deanery, Torbay Hospital, South Devon Healthcare Trust, Torquay, United Kingdom

Received: 04-Mar-2023, Manuscript No. fmijcr-23-91597; Editor assigned: 06- Mar-2023, Pre-QC No. fmijcr-23-91597 (PQ); Reviewed: 20-Mar-2023, QC No. fmijcr-23-91597; Revised: 24-Mar- 2023, Manuscript No. fmijcr-23-91597 (R); Published: 30-Mar-2023, DOI: 10.37532/1758-4272.2023.18 (3).37-40


Background Early temporal roadway vivisection is recommended in all cases with suspected cranial GCA (Giant Cell Arteritis) by the BSR (British Society of Rheumatology) and BHPR (British Health Professionals in Rheumatology) guidelines. This should be performed within one week immaculately. Aim To assess ACR (American College of Rheumatology) score at donation and whether temporal roadway vivisection affects clinical operation of the clinically suspected GCA case. Materials and methods Case records of all temporal roadway necropsies performed within January 2012 until December 2014 were analysed for size and result of vivisection and this was identified to clinical operation following result. Results 129 temporal highways were biopsied with a aggregate of 17 positive vivisection results. 10 vivisection samples were inadequate to confirm or refute GCA. 8 cases within the necropsies negative for GCA had their prednisolone remedy stopped. 5 cases had unknown follow up, with the remainder (89, 87.3) of the cases continued prednisolone operation for treatment of GCA for at least 6 weeks. Conclusions Overall13.2 of our necropsies was positive for GCA and87.3 of vivisection negative cases continued prednisolone remedy on clinical grounds. In the face of new individual tests (high resolution MRI (glamorous Resonance Imaging), colour duplex USS (Ultra Sound overlook) and PET (Positive Emission Topography) can we justify invasive surgery to all cases on histological grounds when the results may not alter operation? farther disquisition is demanded directly comparing newer imaging modalities to histology


Chikungunya fever • Epidemic • Consensus • Brazil


Mammoth cell arteritis (GCA) is a seditious Vasculopathy affecting medium- and largesized highways. Also appertained to as temporal arteritis, it characteristically affects branches of the carotid roadway. While the superficial temporal branch of the carotid roadway is particularly susceptible, highways at any point can be affected. Temporal arteritis is defined by a granulomatous panarteritis with mononuclear cell infiltrates and giant cell conformation within the vessel wall. It's among the common causes of acute blindness and is a medical exigency. Visual loss occurs in over to one- fifth of cases. Guidelines from the British Society of Rheumatology (BSR), British Health Professionals in Rheumatology (BHPR) and the European League against Rheumatism (EULAR) recommend initiating treatment incontinently if giant cell arteritis is suspected. High- cure prednisolone has been shown, during decades of clinical practice, to be a veritably effective treatment.

Early temporal roadway vivisection (TAB) is recommended in all cases with suspected cranial GCA by the BSR and BHPR guidelines 2010, which is reflected in the NICE guidance 2014( National Institute of Clinical Excellence). This should be performed within one week immaculately; still the guidelines and substantiation suggest TAB may remain positive for 2 – 6 weeks following inauguration of glucocorticosteroids.

Still, or typical findings on ultrasound, or ischaemic complications typical of GCA (similar as anterior ischaemic optical neuritis), If vivisection negative the guidelines recommend continuing treatment if “there is a typical clinical and laboratory picture and response to glucocorticosteroids [1, 2].

Materials and Methods

In designing this cohort study we followed the (Strengthening the Reporting of Observational Studies in Epidemiology) STROBE guidelines and the study was registered on exploration registry under UIN 897.

A prospectively maintained database was queried for all TABs performed between01/2012 until03/2014 at a original District General Hospital. All cases' records were analysed for demographical data and histology. Discharge summaries for posterior admissions and GP records were queried for the treatment instigated and whether the operation was altered 6 weeks post vivisection. Statistical analyses were performed using SPSS (IBM ©), descriptive statistics used are indicated within the tables they're quoted. Sanitarium occasion database, discharge summaries latterly were analysed for the presence of prednisolone on dischargesummaries. However, GP records were consulted, If records were negative for prednisolone 6 weeks after TAB [3, 4].


Time from referral to vivisection was performed within 7 days in 102 necropsies. Overall the number of positive necropsies remains low with an outside of13.2. At our unit we've a day case pathway for temporal roadway vivisection. This allows rapid-fire referral to treatment times by one of two general surgeons lists doubly weekly. Then the case is assessed, acceded and operated on within the same session. Demographical data was statistically insignificant between groups except for coitus which was significant. This is to be anticipated as womanish coitus is a well- established threat factor for GCA.

After 7 days only one positive vivisection result was set up. Still81.4 of all necropsies performed at our institution is done so within 7 days. As similar there isn't enough substantiation within our study to support whether TAB positive results will remain positive for a time beyond seven days as former substantiation suggests.

Presently our unit follows the BSR and NICE guidelines on TAB being performed in all cases suspected of having GCA. still Table 5 shows that nearly 83 of cases by time of donation will have an ACR score of 3 or further and by American( ACR) guidelines would not warrant a vivisection; having sufficient clinical grounds to diagnose GCA( perceptivity93.5 and particularity 91.2).

In our study nearly 8 out of 10 cases had a negative vivisection result and only7.8 of these cases had their operation altered latterly. The average vivisection length recommended by the BSR guidelines is 1 cm, of which are average is over in this cohort, still there were a number of samples that fell below this minimal recommended size of 1 – 2 cm. Interestingly in the TAB negative group84/89 cases had an ACR ≥ 3; this is largely reflective that the reason steroids were continued after 6 weeks was on clinical grounds [5, 6]

Farther study and discussion are demanded on the felicitousness of TAB as a individual test given the small number whose operation is altered grounded on the result. In cases with a classical clinical donation the opinion of GCA is straightforward with TAB furnishing histological evidence only. Numerous argue that this evidence is demanded with the average GCA case entering 1 time's treatment of prednisolone with a 50 threat of relapse.

By discrepancy, the opinion becomes grueling with nonspecific symptoms, which may present in the wide range of GCA instantiations. Our study concurs with other literature which has set up analogous rates of vivisection results to our own with low perceptivity, high false negative rates and thus the threat of under discovery. There are numerous reasons for a low volley rate including skip lesions and steroid remedy duration previous to vivisection. Within our study we've tried to exclude the ultimate with the short time to vivisection from referral; but this relies on the case presenting within a short time of symptom onset and the pertaining clinician starting treatment in confluence with referral.

It's clear that a temporal roadway vivisection comprises only 1 point from a possible 5 points in order to make the opinion of temporal arteritis. It has been shown in a study of 111 temporal roadway necropsies that 75(67.5) of these cases formerly had an American College of Rheumatology score of 3 or lesser before a vivisection was performed and so the vivisection shouldn't have affected operation in this subset of cases. The result of a temporal roadway vivisection isn't always fleetly available. Given the nature of complications of giant cell arteritis, treatment is introduced or discontinued before vivisection results are available in 60 – 86 of cases.

Temporal roadway necropsies aren't without complications and difficulties. These have included unintended necropsies of modes and jitters, postoperative haematoma, crown necrosis, crack infection, damage to the facial whim-whams, and drooping of the eyebrow. As well as ornamental consequences of incisional alopecia, widening of the scar and foreign body response to entangled hairs. Still it's a safe procedure, performed constantly with excellent issues in utmost units around the country [7, 8].


Numerous new modalities which Arnon-invasive are demonstrating a growing substantiation base in the opinion of GCA. It's now getting apparent that GCA is a much more complex complaint with associations including polymyalgia rheumatic, aneurysm conformation and redundant cranial vessel involvement. Numerous units report low vivisection positive rates but these do vary; this concurs with our own results in this study. In our study we've shown that 83 of our case would have experience vivisection if following ACR guidelines.

Temporal roadway vivisection is an invasive surgery that carries threat. It's the authors’ opinion that temporal roadway vivisection needs direct comparison with newer modalities similar as CDS, PET or MRI that have in numerous studies to date shown similar high particularity and perceptivity. New data arising suggests that CDS can achieve analogous particularity with a better perceptivity.

As a lower totalitarian approach as to whether to perform TAB we'd argue a further targeted approach with biopsying those cases who have a clinical GCA opinion that doesn't fulfil the American College of Rheumatology individual criteria with the disquisition in the future as to whether individual imaging could further reduce the number we vivisection. Still this would have to be offered in a timely fashion to insure that vivisection isn't delayed thus dwindling the liability of achieving a positive result [9, 10].


The authors admit and thank all members of the day case surgery unit platoon and the nanny interpreters. The authors declare no conflict of interest

Conflict of Interest



  1. Stammler F, Grau C, Schnabel A et al. [Value of colour Doppler ultrasonography in relation to clinical pretest probability in giant cell (temporal) arteritis]Dtsch Med Wochenschr. 134, 2109-2115 (2009).
  2. Indexed at, Google Scholar, Crossref

  3. Klink T, Geiger J, Both M et al. Giant cell arteritis, diagnostic accuracy of MR imaging of superficial cranial arteries in initial diagnosis-results from a multicenter trial. Radiology. 273, 844- 852 (2014).
  4. Indexed at, Google Scholar, Crossref

  5. Quinn EM, Kearney DE, Kelly J et al. Temporal artery biopsy is not required in all cases of suspected giant cell arteritis. Ann Vasc Surg. 26, 649-654 (2012).
  6. Indexed at, Google Scholar, Crossref

  7. Prieto-Peña D, Castañeda S, Martínez-Rodríguez I et al. Imaging Tests in the Early Diagnosis of Giant Cell Arteritis. J Clin Med. 10, 3704 (2021).
  8. Indexed at, Google Scholar, Crossref

  9. Murchison AP, Gilbert ME, Bilyk JR et al. Validity of the American College of Rheumatology criteria for the diagnosis of giant cell arteritis. Am J Ophthalmol. 154,722-729 (2012).
  10. Indexed at, Google Scholar, Crossref

  11. Grossman C, Barshack I, Koren-Morag N et al.  Baseline clinical predictors of an ultimate giant cell arteritis diagnosis in patients referred to temporal artery biopsy. Clin Rheumatol. 35, 1817-1822 (2016).
  12. Indexed at, Google Scholar, Crossref

  13. Bley TA, Wieben O, Uhl M et al. High-resolution MRI in giant cell arteritis, imaging of the wall of the superficial temporal artery. AJR Am J Roentgenol. 184, 283-287 (2005).
  14. Indexed at, Google Scholar, Crossref

  15. Bley TA, Reinhard M, Hauenstein C et al.  Comparison of duplex sonography and high-resolution magnetic resonance imaging in the diagnosis of giant cell (temporal) arteritis. Arthritis Rheum. 58, 2574-2578 (2008).
  16. Indexed at, Google Scholar, Crossref

  17. Karahaliou M, Vaiopoulos G, Papaspyrou S et al. Colour duplex sonography of temporal arteries before decision for biopsy, a prospective study in 55 patients with suspected giant cell arteritis. Arthritis Res Ther. 8, R116 (2006).
  18. Indexed at, Google Scholar, Crossref

  19. Hussain O, McKay A, Fairburn K et al. Diagnosis of giant cell arteritis, when should we biopsy the temporal artery? Br J Oral Maxillofac Surg. 54, 327-330 (2016).
  20. Indexed at, Google Scholar, Crossref

Awards Nomination 20+ Million Readerbase

Select your language of interest to view the total content in your interested language

Google Scholar citation report
Citations : 5529

International Journal of Clinical Rheumatology received 5529 citations as per Google Scholar report

International Journal of Clinical Rheumatology peer review process verified at publons

Indexed In